ABUS vs CBAT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

ABUS

39.2
AI Score
VS
CBAT Wins

CBAT

33.4
AI Score

Investment Advisor Scores

ABUS

39score
Recommendation
EXTENDED

CBAT

33score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric ABUS CBAT Winner
Forward P/E 10.2459 8.2713 CBAT
PEG Ratio 0 0 Tie
Revenue Growth -90.6% 99.3% CBAT
Earnings Growth 0.0% 15062.1% CBAT
Tradestie Score 39.2/100 33.4/100 ABUS
Profit Margin 84.2% -7.4% ABUS
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED EXTENDED Tie

Relative Price Performance (Last 90 Days)

ABUS 1M: +16.6% · 3M: +17.3% CBAT 1M: +64.6% · 3M: +10.8%

Current Technical Phase

ABUS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.2% over 20 days), RSI 67

RSI (14): 66.9 · Price: $5.21

CBAT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 71

RSI (14): 71.3 · Price: $0.82

Fundamentals Snapshot

Metric ABUS CBAT
Market Cap
Forward P/E -46.9 3.4
Trailing P/E 6.0
Revenue (TTM)
Revenue Growth -0.9% 1.0%
Gross Margin 0.9% 0.1%
Operating Margin -5.7% -0.1%
EPS 0.79 -0.21
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CBAT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.